Lv1
36 积分 2024-11-13 加入
High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effect
2天前
已完结
A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanoma
2天前
已完结
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease
11天前
已完结
siRNA therapy markedly reduces Lp(a) levels
12天前
已完结
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
17天前
已完结
皖公网安备34019202002308
